Skip to main content

Is Infertility Genetic? What Two Twin Studies and 3,060 Karyotypes Actually Show (2026)

IVF Education · November 13, 2026
ProIVF Medical Editorial Team · ProIVF Medical Advisory Board reviewed
Is infertility geneticHeritability of infertilityY chromosome microdeletionCFTR CBAVDFMR1 premature ovarian insufficiencyGenetic counseling before IVF
Is Infertility Genetic? What Two Twin Studies and 3,060 Karyotypes Actually Show (2026)

Infertility is genetic in a few specific, testable ways and barely genetic in the general sense. A Danish twin study of 9,053 people attributes 28% of the variation in women’s time to pregnancy to inherited factors, and only 4% in men.

This article was prepared by the ProIVF medical editorial team from the peer-reviewed studies cited in the text, with every figure traced to its original publication, and reviewed by the ProIVF Medical Advisory Board. We separate what inheritance explains about a population from what it predicts about one couple, because those two answers differ sharply.

Is infertility genetic?

Partly, and the “partly” is smaller than most family histories suggest. Inheritance reliably explains a handful of named conditions, while the commonest presentation — a couple with no diagnosis after a full workup — is mostly not inherited.

The confusion comes from mixing two questions. One asks whether a specific condition has a genetic cause: for a man with no sperm in the ejaculate, the answer is often yes, and the cause is findable. The other asks whether infertility in general runs in families: for the population, the answer is a modest yes in women and an almost negligible yes in men.

Scale matters when reading any of this. WHO estimates that about one in every six people of reproductive age worldwide experiences infertility in their lifetime, and the dominant drivers remain age, tubal damage, ovulation disorders and sperm production rather than single-gene disorders (WHO fact sheet).

What heritability actually measures

Heritability is the share of variation between people that is attributable to genetic differences, measured in one population at one moment. It says nothing about why one individual is infertile.

That distinction matters when a patient reads “28% heritable” and concludes that a parent passed something on. A trait can be 100% genetic in mechanism and still have low heritability if everyone in the population carries the same genes; a trait with no single gene cause can show moderate heritability because thousands of small variants add up.

The 28% and the 4%

The best available estimate comes from 9,053 same-sex Danish twin pairs born between 1931 and 1976, analysed with a liability threshold model on time to first pregnancy with a 10-month cut-off (Fertility and Sterility, 2020).

MeasureWomenMen
Additive genetic contribution28% (95% CI 15–41)4% (95% CI 0–22)
Unique environmental contribution72% (95% CI 59–85)96% (95% CI 78–100)
Sample9,053 Danish twins9,053 Danish twins

The authors were direct about the implication, and it is worth quoting rather than paraphrasing:

“Unique environmental factors explain most of the observed variation in subfertility, when measured as waiting time to pregnancy.” — Heritability of subfertility among Danish twins, Fertility and Sterility, 2020

For a Chinese couple reading this before booking a cycle, the practical meaning is that a negative family history is not reassurance and a positive one is not a verdict. Neither replaces a semen analysis, a karyotype when indicated, or a carrier panel.

What do twin studies show about infertility running in families?

Two large twin studies found familial clustering but weak evidence for genes, which is a more interesting result than it first appears. Clustering means infertility concentrates in some families; the missing genetic signal means the cause is more likely shared environment, shared age at first attempt, or chance.

The male twin result that surprised researchers

The Vietnam Era Twin Registry followed 1,795 complete male twin pairs and asked about 12-month male-factor infertility (Paediatric and Perinatal Epidemiology, 2007).

  • Proband concordance was 38% in identical pairs and 33% in fraternal pairs, a gap too small to prove a genetic effect.
  • Tetrachoric correlation was 0.15 in identical pairs and 0.04 in fraternal pairs.
  • The formal test of genetic influence did not reach significance at P = 0.21.

The authors’ conclusion is the useful part: male infertility clustered within families, but factors unique to each individual twin mattered more than either shared genes or a shared childhood.

Where the same method finds strong inheritance

The method is not blind. Applied to the age at natural menopause in the same kind of twin design, it produces heritability estimates of 0.85 to 0.87 (Human Reproduction, 2001).

That contrast is the cleanest way to read the 28% figure. A trait controlled by the timing of ovarian follicle depletion is highly heritable. A couple’s waiting time to pregnancy is not, because it folds in sperm production, tubal status, coital frequency, age, body weight and luck.

Which causes of infertility are genuinely inherited?

A short list of conditions accounts for nearly all of the inheritance that a clinic can act on. Each has a named gene or chromosome region, a defined inheritance pattern, and a test that a reproductive endocrinologist can order.

ConditionGenetic basisShare of the relevant groupWhat a child can inherit
Y-chromosome microdeletion (AZF)Deletions on Yq12.70% of azoospermia, 5.99% of oligozoospermiaThe same deletion, in every son
Congenital bilateral absence of the vas deferensCFTR variants, plus ADGRG2~0.1% of menCFTR variants; carrier status
Premature ovarian insufficiencyChromosomal (10–13%), FMR1 premutation, single genes20–25% have a genetic causeFMR1 premutation, X abnormalities
Balanced translocationStructural rearrangementEnriched in recurrent lossUnbalanced chromosomes, miscarriage risk
Congenital hypogonadotropic hypogonadismMultiple genes (CHH panel)8.3% of one azoospermia cohortUsually recessive or de novo

Y-chromosome microdeletions pass to every son

AZF deletions sit on the long arm of the Y chromosome and are transmitted intact through ICSI, because the technique bypasses the natural barriers that would otherwise stop those sperm from fertilising an egg. Every male offspring of a carrier father inherits the deletion (Journal of Andrology, 1999).

This is inheritance by mechanism, not a side effect of the laboratory. The clinical consequence is counselling: a father with an AZFc deletion who has a son through ICSI should expect that son to face the same fertility problem at the same age, and to need the same kind of help.

CFTR, CBAVD and the 10–20% with no answer

Congenital absence of the vas deferens affects roughly 0.1% of men and is the classic genetic cause of obstructive azoospermia. Most cases trace to CFTR variants, with a smaller share from ADGRG2.

The uncomfortable finding is that 10–20% of CBAVD cases still have no genetic diagnosis after testing (Human Genetics, 2021). A negative panel therefore closes a door on explanation, not on treatment: sperm can still be retrieved from the testis and used for ICSI.

FMR1 and premature ovarian insufficiency

Premature ovarian insufficiency — loss of ovarian function before 40 — has an identifiable genetic cause in 20–25% of cases, of which chromosomal abnormalities account for 10–13% (Porto Biomedical Journal, 2020).

FMR1 premutation carriers face a lifetime POI risk of about 20%, which is why FMR1 testing is standard in any young woman with rising FSH and a shrinking antral follicle count. The same test carries a second implication: a premutation can expand to a full mutation in the next generation, which is a fragile X syndrome risk rather than an infertility risk.

How much male infertility has a findable genetic cause?

In a retrospective cohort of 3,060 men treated for infertility at one Chinese university hospital, 8.24% carried a Y-chromosome microdeletion and 8.01% had an abnormal karyotype (Medicine, 2025).

The severity gradient is what makes those numbers usable in clinic. Y microdeletions were found in 12.70% of men with azoospermia and 5.99% of men with oligozoospermia, while karyotype abnormalities ran 15.72% versus 4.13% across the same split. A separate Chinese screening study of 4,714 infertile men reported an overall microdeletion rate of 3.31%, rising from 0.17% in the mildest group to 7.54% in the most severe (PMID 38053137).

Why the sperm count decides the test order

The lower the sperm concentration, the higher the pre-test probability, and the more a karyotype plus Y microdeletion panel earns its cost. Above roughly 5 million motile sperm per millilitre, the yield falls far enough that many guidelines stop at history, examination and hormone profile.

In a cohort of 466 men with azoospermia, 15.4% received a genetic diagnosis: CFTR in 31.9% of those diagnosed, 47,XXY in 30.6%, Y microdeletions in 19.4%, structural abnormalities in 9.7% and congenital hypogonadotropic hypogonadism in 8.3% (PMID 39124666). Read that list as a testing menu, not as a set of rarities.

What a karyotype adds that a panel cannot

A microdeletion panel targets one chromosome region. A karyotype counts all 46 chromosomes and catches what the panel misses: a 47,XXY Klinefelter pattern, a Robertsonian translocation, a pericentric inversion.

Both tests are blood draws and both are usually ordered together when the sperm count is very low. Doing only the panel leaves the most common chromosomal cause of male infertility undetected.

Does IVF pass infertility on to your children?

Sometimes the mechanism is transmitted, and the effect is measurable but modest. In the first follow-up of young adults conceived by ICSI for male infertility, 54 men aged 18 to 22 had a median sperm concentration of 17.7 million/ml against 37.0 million/ml in 57 spontaneously conceived peers (Human Reproduction, 2016).

After adjustment for age, BMI, genital malformations, abstinence time and time from ejaculation, ICSI-conceived men were 2.7 times more likely to fall below the WHO reference of 15 million/ml (95% CI 1.1–6.7) and 4.3 times more likely to have a total sperm count under 39 million (95% CI 1.7–11.3).

What those odds ratios do and do not mean

They mean a father with severe male-factor infertility should assume his son may need a semen analysis at 18, not that his son will be infertile. Median values stayed inside the WHO reference range, and the study is small.

They also do not apply to every ICSI case. The cohort was conceived for male-factor infertility specifically, so the finding describes transmitted sperm-production problems, not the technique itself.

What PGT-M can and cannot prevent

Preimplantation genetic testing for monogenic disorders can stop a known single-gene condition from being passed on, because it tests embryos for the specific variant the parents carry. It cannot screen out polygenic risk, and it cannot improve the inheritance picture for a condition nobody has sequenced.

For a couple with a known CFTR variant, a balanced translocation or an FMR1 premutation, PGT-M plus genetic counselling changes the odds materially. For a couple with unexplained infertility and no family history, PGT-M has nothing to test.

What should you do if infertility runs in your family?

Start with the cheapest test that can change a decision, and let the result decide the next one. A family history of azoospermia, repeated miscarriage, or early menopause is a reason to order tests earlier, not a reason to skip straight to IVF.

A three-step order of testing

  1. Semen analysis and hormone profile first. FSH, LH, total testosterone and two semen samples define whether a genetic test has any yield.
  2. Karyotype plus Y microdeletion panel if the sperm count is severely low or zero; add CFTR testing if the vas deferens cannot be felt.
  3. Carrier screening for both partners before embryo creation, so that a recessive result arrives in time to plan rather than after a failed transfer.

Carrier screening finds more than most couples expect. In a program that exome-sequenced 8,280 infertile patients and 5,845 gamete donors, 4.8% of 776 IVF couples were at increased reproductive risk, and the modelled risk of a highly penetrant childhood-onset disorder was 1 in 337 conceptions (PLoS Genetics, 2019).

Who should not be tested

A couple with a normal semen analysis, regular ovulation, open tubes, a normal karyotype already done elsewhere, and no family history gains little from repeating a panel. The same is true for a 42-year-old whose limiting factor is oocyte aneuploidy rather than a single gene.

Testing has a cost beyond money: a variant of uncertain significance can stall a cycle while everyone waits for a classification that never resolves. Order the test whose result would change what you do next week.

For the test-by-test version of this decision, including costs and turnaround, see our guide to genetic testing for infertility. For how embryos are actually screened after retrieval, see PGT-A and PGT-M explained.

What do patients with a family history actually face?

The three cases below are composites of common paths, written for illustration. They do not describe identifiable individuals, and names and some details have been changed.

Wei, 34, Shenzhen: two brothers, one deletion

Wei’s older brother had no sperm on two analyses and was told at 29 that donor sperm was the only route. When Wei’s own analysis came back at 0.4 million/ml, his wife asked whether the pattern was inherited.

A Y microdeletion panel found an AZFc deletion in both brothers, and a karyotype was normal. Wei’s retrieval yielded sperm for ICSI; the couple paid about ¥38,000 for the cycle in Shenzhen and had a son in 2024. Their counsellor spent more time on the son than on the father: “She told us our boy will need a semen analysis at 18, and that this is information, not a sentence.”

Priya, 31, London: a premutation found by accident

Priya was referred for IVF after eight months of trying and a rising FSH of 14 IU/L at 31. Her AMH was 0.7 ng/ml and her mother had entered menopause at 39.

FMR1 testing found a premutation of 78 repeats, which reframed the whole plan: POI risk around 20%, a fragile X expansion risk for a daughter, and a reason to freeze embryos rather than wait. The couple did one cycle at a private London clinic for about £9,500 including medication, banked three euploid embryos, and transferred one. “Nobody in my family had ever called it infertility,” she said. “It was just that the women stopped early.”

Marcus, 38, Ohio: a translocation and no cycle

Marcus and his wife had three miscarriages between 2019 and 2022, all before nine weeks. A karyotype on Marcus found a balanced translocation; his wife’s karyotype was normal.

Their clinic offered PGT-SR on embryos rather than another natural attempt, at roughly $4,200 for the biopsy and testing on top of a $13,000 cycle. They produced four blastocysts, one of which was balanced, and that transfer is ongoing at 22 weeks. “The first genetic result we got was the first time anyone explained the miscarriages,” he said.

FAQ

Q: Is infertility genetic?

Partly. Twin data attribute 28% of the variation in women’s time to pregnancy and 4% in men to inherited factors, but specific conditions such as Y microdeletions and CFTR variants are strongly inherited and testable.

Q: What percentage of male infertility has a genetic cause?

In one cohort of 3,060 men, 8.24% carried a Y microdeletion and 8.01% had an abnormal karyotype, with azoospermia roughly doubling both rates at 12.70% and 15.72%.

Q: Can I inherit infertility from my mother?

Yes, in specific forms. FMR1 premutation carriers have about a 20% lifetime risk of premature ovarian insufficiency, and the age at natural menopause is 85% heritable, which is far higher than infertility itself.

Q: Does IVF pass on male infertility to a son?

The mechanism can be transmitted, and the effect is measurable: ICSI-conceived young men had a median sperm concentration of 17.7 million/ml against 37.0 million/ml in peers, with 2.7 times the odds of falling below 15 million/ml.

Q: Will PGT-A stop my child inheriting my infertility?

No. PGT-A counts the 46 chromosomes in an embryo and does not change which genes you pass on; only PGT-M, aimed at a variant you already know you carry, prevents transmission of that specific variant.

Q: Should both partners have carrier screening before IVF?

Yes, ideally before embryo creation. In one exome-sequencing program, 4.8% of 776 IVF couples were at increased reproductive risk, and screening costs a fraction of a single cycle.

Q: Is a family history of infertility worth investigating before starting IVF?

It is worth one clinic visit. A history of azoospermia, early menopause or three or more miscarriages changes the first test you should order, and a karyotype plus panel costs far less than a wasted cycle.

How to plan the next step

Bring the family history to the first appointment as a written list: who, at what age, what diagnosis, and whether the diagnosis was ever confirmed by a test. That single page determines whether your first order is a semen analysis, a karyotype, an FMR1 test or a carrier panel.

If a genetic cause is found, the plan should include a counsellor and a conversation about the next generation, not only about this cycle. For clinics where genetic counselling sits inside the treatment pathway, browse the hospital directory; to ask us to match a case with a centre that handles your specific variant, contact the ProIVF team.

Medical disclaimer. This article is educational and does not replace individual medical advice, diagnosis or treatment. Genetic test selection depends on your history, examination and local laboratory. Discuss any result with a clinical geneticist or your reproductive endocrinologist before making treatment decisions.

How this article was made. The ProIVF medical editorial team drafted this piece from the peer-reviewed sources linked in the text, checked every percentage against its abstract, and excluded claims we could not trace to a publication. The ProIVF Medical Advisory Board reviewed the clinical framing, including the distinction between heritability and individual risk. Read our editorial process and team.

Last updated: 13 November 2026.

Ready to start your fertility journey?

Get a personalized plan from our medical advisors